Controlling the trafficking of JAM-C and its cotrafficked counterparts could potentially provide novel ways of limiting disease states, particularly those associated with increased levels of cell-surface JAM-C such as atherosclerosis and arthritis. The gene discussed is JAM3; the disease is atherosclerosis.